Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-12-13 5:15 pm Sale |
2024-12-13 | 13G | AC Immune SA ACIU |
AFFIRIS AG in Liqu | 6,428,100 6.500% |
-150,000 (-2.28%) |
Filing History |
| 2024-11-14 4:36 pm Purchase |
2024-09-30 | 13G | AC Immune SA ACIU |
BIOTECHNOLOGY VALUE FUND L P | 19,522,436 19.700% |
4,951,200 (+33.98%) |
Filing History |
| 2024-02-09 4:30 pm Sale |
2023-12-15 | 13G | AC Immune SA ACIU |
AFFIRIS AG in Liqu | 6,578,100 6.660% |
-146,740 (-2.18%) |
Filing History |
| 2023-12-19 4:53 pm Purchase |
2023-12-15 | 13G | AC Immune SA ACIU |
BIOTECHNOLOGY VALUE FUND L P | 14,571,236 14.800% |
7,142,857 (+96.16%) |
Filing History |
| 2023-02-14 5:15 pm Sale |
2022-10-06 | 13G | AC Immune SA ACIU |
AFFIRIS AG in Liqu | 6,724,840 8.060% |
-1,895,317 (-21.99%) |
Filing History |
| 2023-02-13 5:53 pm Purchase |
2022-12-31 | 13G | AC Immune SA ACIU |
BIOTECHNOLOGY VALUE FUND L P | 7,428,379 8.900% |
366,000 (+5.18%) |
Filing History |
| 2023-02-10 4:01 pm Sale |
2022-12-31 | 13G | AC Immune SA ACIU |
dievini Hopp BioTech holding GmbH & Co KG | 16,316,742 19.500% |
-1,724,258 (-9.56%) |
Filing History |
| 2023-01-27 4:41 pm Unchanged |
2022-12-31 | 13G | AC Immune SA ACIU |
LILLY ELI & CO LLY |
3,615,328 4.300% |
0 (Unchanged) |
Filing History |
| 2022-02-14 1:41 pm Sale |
2021-12-31 | 13G | AC Immune SA ACIU |
BIOTECHNOLOGY VALUE FUND L P | 7,062,379 9.700% |
-854,279 (-10.79%) |
Filing History |
| 2022-02-14 1:37 pm Sale |
2021-12-31 | 13G | AC Immune SA ACIU |
EcoR1 Capital LLC | 749,585 0.900% |
-3,952,575 (-84.06%) |
Filing History |
| 2021-08-05 5:15 pm Purchase |
2021-07-26 | 13G | AC Immune SA ACIU |
AFFIRIS AG in Liqu | 8,620,157 10.100% |
8,620,157 (New Position) |
Filing History |
| 2021-02-12 4:50 pm Purchase |
2020-12-31 | 13G | AC Immune SA ACIU |
LILLY ELI & CO LLY |
3,615,328 5.000% |
3,615,328 (New Position) |
Filing History |
| 2021-02-12 10:59 am Sale |
2020-12-31 | 13G | AC Immune SA ACIU |
dievini Hopp BioTech holding GmbH & Co KG | 18,041,000 25.100% |
-174,750 (-0.96%) |
Filing History |
| 2021-01-22 4:27 pm Purchase |
2021-01-12 | 13G | AC Immune SA ACIU |
EcoR1 Capital LLC | 4,702,160 6.600% |
4,702,160 (New Position) |
Filing History |
| 2021-01-14 4:48 pm Sale |
2021-01-12 | 13G | AC Immune SA ACIU |
BIOTECHNOLOGY VALUE FUND L P | 7,916,658 11.000% |
-3,425,847 (-30.20%) |
Filing History |